Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Operating Leases (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Operating Leases for 3 consecutive years, with $4.3 million as the latest value for Q1 2026.

  • Quarterly Operating Leases rose 49.41% to $4.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Jan 2026, up 49.41% year-over-year, with the annual reading at $3.0 million for FY2025, 14.93% up from the prior year.
  • Operating Leases for Q1 2026 was $4.3 million at Kestra Medical Technologies, up from $2.9 million in the prior quarter.
  • The five-year high for Operating Leases was $4.3 million in Q1 2026, with the low at $2.6 million in Q2 2024.
  • Average Operating Leases over 3 years is $3.1 million, with a median of $2.9 million recorded in 2025.
  • The sharpest move saw Operating Leases increased 14.93% in 2025, then soared 49.41% in 2026.
  • Over 3 years, Operating Leases stood at $2.6 million in 2024, then increased by 9.15% to $2.9 million in 2025, then skyrocketed by 48.78% to $4.3 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods came in at $4.3 million, $2.9 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.